JAVIER
ESCANED BARBOSA
Profesor asociado de Ciencias de la Salud
![Foto de JAVIER](/img/uploaded/B1C208A8E1820F13282153D4BA39B96E.jpg)
![Foto de Columbia University Medical Center](/img/noimage_org.png)
Columbia University Medical Center
Nueva York, Estados UnidosPublicacións en colaboración con investigadores/as de Columbia University Medical Center (26)
2024
-
Correction to: Optical coherence tomography in coronary atherosclerosis assessment and intervention (Nature Reviews Cardiology, (2022), 19, 10, (684-703), 10.1038/s41569-022-00687-9)
Nature Reviews Cardiology
-
Dynamic Coronary Roadmap versus standard angiography for percutaneous coronary intervention: the randomised, multicentre DCR4Contrast trial
EuroIntervention, Vol. 20, Núm. 3, pp. e198-e206
-
Global Consensus Recommendations on Improving the Safety of Chronic Total Occlusion Interventions
Heart Lung and Circulation, Vol. 33, Núm. 7, pp. 915-931
2023
-
Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary Intervention
JACC: Cardiovascular Interventions, Vol. 16, Núm. 20, pp. 2514-2524
-
Long-term outcomes of patients with normal fractional flow reserve and thin-cap fibroatheroma
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 13, pp. e1099-e1107
-
Morphological characteristics of lesions with thin cap fibroatheroma-a substudy from the COMBINE (OCT-FFR) trial
European heart journal. Cardiovascular Imaging, Vol. 24, Núm. 5, pp. 687-693
-
Rationale and design of the Dynamic Coronary Roadmap for Contrast Reduction (DCR4Contrast) in PCI randomized controlled trial
American Heart Journal, Vol. 263, pp. 151-158
2022
-
Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index
JACC: Cardiovascular Interventions, Vol. 15, Núm. 19, pp. 1948-1960
-
Optical coherence tomography in coronary atherosclerosis assessment and intervention
Nature Reviews Cardiology, Vol. 19, Núm. 10, pp. 684-703
-
Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 17, Núm. 16, pp. 1330-1339
-
Thin-Cap Fibroatheroma Rather Than Any Lipid Plaques Increases the Risk of Cardiovascular Events in Diabetic Patients: Insights from the COMBINE OCT-FFR Trial
Circulation: Cardiovascular Interventions, Vol. 15, Núm. 5, pp. E011728
-
Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKD
European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 7, pp. 707-716
2021
-
Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial
The Lancet, Vol. 398, Núm. 10317, pp. 2149-2159
-
Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review
Journal of the American College of Cardiology, Vol. 78, Núm. 8, pp. 840-853
-
Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI
JACC: Cardiovascular Interventions, Vol. 14, Núm. 13, pp. 1434-1446
-
Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trial
European heart journal, Vol. 42, Núm. 45, pp. 4671-4679
-
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR
European Heart Journal, Vol. 42, Núm. 45, pp. 4624-4634
-
Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD
European Heart Journal, Vol. 42, Núm. 45, pp. 4683-4693
2020
-
Quantitative flow ratio–guided strategy versus angiography-guided strategy for percutaneous coronary intervention: Rationale and design of the FAVOR III China trial
American Heart Journal, Vol. 223, pp. 72-80
-
Ticagrelor alone vs.Ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS
European Heart Journal, Vol. 41, Núm. 37, pp. 3533-3545